Literature DB >> 20121432

Recurrent tuberculosis: relapse, reinfection, and HIV.

Richard E Chaisson1, Gavin J Churchyard.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20121432      PMCID： PMC3407677          DOI： 10.1086/650531

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  18 in total

1.  The in vitro evolution of BCG vaccines.

Authors:  Serge Mostowy; Anthony G Tsolaki; Peter M Small; Marcel A Behr
Journal:  Vaccine       Date:  2003-10-01       Impact factor: 3.641

2.  Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.

Authors:  A Vernon; W Burman; D Benator; A Khan; L Bozeman
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

3.  HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers.

Authors:  P Sonnenberg; J Murray; J R Glynn; S Shearer; B Kambashi; P Godfrey-Faussett
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

4.  Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial.

Authors:  D W Fitzgerald; M Desvarieux; P Severe; P Joseph; W D Johnson; J W Pape
Journal:  Lancet       Date:  2000-10-28       Impact factor: 79.321

5.  Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons.

Authors:  T R Sterling; K Alwood; R Gachuhi; W Coggin; D Blazes; W R Bishai; R E Chaisson
Journal:  AIDS       Date:  1999-10-01       Impact factor: 4.177

6.  Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review.

Authors:  Eline L Korenromp; Fabio Scano; Brian G Williams; Christopher Dye; Paul Nunn
Journal:  Clin Infect Dis       Date:  2003-06-23       Impact factor: 9.079

7.  Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection.

Authors:  P M Small; R W Shafer; P C Hopewell; S P Singh; M J Murphy; E Desmond; M F Sierra; G K Schoolnik
Journal:  N Engl J Med       Date:  1993-04-22       Impact factor: 91.245

8.  Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?

Authors:  Gavin J Churchyard; Katherine Fielding; Salome Charalambous; John H Day; Elizabeth L Corbett; Richard J Hayes; Richard E Chaisson; Kevin M De Cock; Badara Samb; Alison D Grant
Journal:  AIDS       Date:  2003-09-26       Impact factor: 4.177

Review 9.  Tuberculosis vaccine research: the impact of immunology.

Authors:  Lewellys F Barker; Michael J Brennan; Peri K Rosenstein; Jerald C Sadoff
Journal:  Curr Opin Immunol       Date:  2009-06-07       Impact factor: 7.486

10.  Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control.

Authors:  E L Corbett; T Bandason; Y-B Cheung; B Makamure; E Dauya; S S Munyati; G J Churchyard; B G Williams; A E Butterworth; S Mungofa; R J Hayes; P R Mason
Journal:  Int J Tuberc Lung Dis       Date:  2009-10       Impact factor: 2.373
View more
  21 in total

1.  Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study.

Authors:  A T Chin; J Rylance; S Makumbirofa; S Meffert; T Vu; J Clayton; P Mason; P Woodruff; J Metcalfe
Journal:  Int J Tuberc Lung Dis       Date:  2019-02-01       Impact factor: 2.373

2.  TB-DOTS Outcome in Relation to HIV Status: Experience in a Medical College.

Authors:  Chennaveerappa P K; Jayashree Nagaral; Nareshkumar M N; Praveen G; Halesha B R; M V Vinaykumar
Journal:  J Clin Diagn Res       Date:  2014-01-12

Review 3.  Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.

Authors:  Linda M Parsons; Akos Somoskövi; Cristina Gutierrez; Evan Lee; C N Paramasivan; Alash'le Abimiku; Steven Spector; Giorgio Roscigno; John Nkengasong
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  Recurrent tuberculosis in an urban area in China: Relapse or exogenous reinfection?

Authors:  Xin Shen; Chongguang Yang; Jie Wu; Senlin Lin; Xu Gao; Zheyuan Wu; Jiyun Tian; Mingyu Gan; Tao Luo; Lili Wang; Chenlei Yu; Jian Mei; Qichao Pan; Kathryn DeRiemer; ZhengAn Yuan; Qian Gao
Journal:  Tuberculosis (Edinb)       Date:  2017-01-31       Impact factor: 3.131

5.  Older age at first tuberculosis diagnosis is associated with tuberculosis recurrence in HIV-negative persons.

Authors:  Y F van der Heijden; F Karim; T Chinappa; G Mufamadi; L Zako; B E Shepherd; F Maruri; M-Y S Moosa; T R Sterling; A S Pym
Journal:  Int J Tuberc Lung Dis       Date:  2018-08-01       Impact factor: 2.373

6.  Predictors and short-term outcomes of recurrent pulmonary tuberculosis, Uganda: a cohort study.

Authors:  Nelson Kalema; Christina Lindan; Dave Glidden; Samuel D Yoo; Achilles Katamba; Andama Alfred; Winceslaus Katagira; Patrick Byanyima; Emmanuel Musisi; Sylvia Kaswabuli; Sanyu Ingvar; Josephine Zawedde; Christina Yoon; Irene Ayakaka; J Lucian Davis; Laurence Huang; William Worodria; Adithya Cattamanchi
Journal:  S Afr Respir J       Date:  2017

7.  Recurrence due to relapse or reinfection with Mycobacterium tuberculosis: a whole-genome sequencing approach in a large, population-based cohort with a high HIV infection prevalence and active follow-up.

Authors:  José Afonso Guerra-Assunção; Rein M G J Houben; Amelia C Crampin; Themba Mzembe; Kim Mallard; Francesc Coll; Palwasha Khan; Louis Banda; Arthur Chiwaya; Rui P A Pereira; Ruth McNerney; David Harris; Julian Parkhill; Taane G Clark; Judith R Glynn
Journal:  J Infect Dis       Date:  2014-10-21       Impact factor: 5.226

8.  A fractional order HIV-TB co-infection model in the presence of exogenous reinfection and recurrent TB.

Authors:  Tanvi A; Rajiv Aggarwal; Yashi A Raj
Journal:  Nonlinear Dyn       Date:  2021-05-28       Impact factor: 5.022

9.  Genetic models of latent tuberculosis in mice reveal differential influence of adaptive immunity.

Authors:  Hongwei Su; Kan Lin; Divya Tiwari; Claire Healy; Carolina Trujillo; Yao Liu; Thomas R Ioerger; Dirk Schnappinger; Sabine Ehrt
Journal:  J Exp Med       Date:  2021-07-16       Impact factor: 14.307

10.  An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse.

Authors:  Patrick P J Phillips; Katherine Fielding; Andrew J Nunn
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.